

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRNA | NASDAQ | USD | Real-time | |
MRNA | Mexico | MXN | Delayed | |
MRNA | Milan | EUR | Real-time | |
0QF | Frankfurt | EUR | Delayed | |
0QF | TradeGate | EUR | Delayed | |
0QF | Xetra | EUR | Delayed | |
MRNAm | Buenos Aires | ARS | Delayed | |
M1RN34 | B3 | BRL | Delayed | |
MRNA | Vienna | EUR | Real-time | |
MRNA_KZ | KASE | USD | Delayed | |
MRNA | Lima | USD | Delayed |
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Scott A. Canute | 64 | 2014 | Member of Technology Advisory Board |
Michael Diamond | - | - | Member of Scientific Advisory Board |
Ron Eydelloth | - | - | Member of Scientific Advisory Board |
Paul L. Sagan | 66 | 2018 | Independent Non Executive Director |
Paula T. Hammond | 61 | - | Member of Scientific Advisory Board |
Stephane Bancel | 52 | 2011 | CEO & Director |
Rachel Green | - | - | Member of Scientific Advisory Board |
Elizabeth G. Nabel | 73 | 2021 | Independent Director |
Ralph Weissleder | - | - | Member of Scientific Advisory Board |
Ulrich H. von Andrian-Werburg | - | - | Member of Scientific Advisory Board |
John G. Aunins | 64 | 2014 | Member of Technology Advisory Board |
James R. Swartz | - | 2014 | Member of Technology Advisory Board |
Shah Abbas Hussain | 60 | 2024 | Director |
Francois Nader | 68 | 2019 | Independent Non Executive Director |
David Mark Rubenstein | 76 | 2024 | Director |
Melissa J. Moore | - | 2016 | Member of Scientific Advisory Board |
Noubar B. Afeyan | 62 | 2010 | Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board |
Robert S. Langer | 76 | 2010 | Member of Scientific Advisory Board |
Elizabeth Edith Tallett | 76 | 2020 | Independent Director |
Jack W. Szostak | - | 2014 | Chairman of Scientific Advisory Board |
Sandra J. Horning | 76 | 2020 | Independent Director |
Richard C. Willson | - | 2014 | Member of Technology Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review